In this large prospective cohort of 4776patients who underwent bariatric surgery, 30-day adverse outcomes (death, thromboembolism, reintervention, or continued hospitalization) occurred in 4% (30-day death was only 0.3%). Higher risk was associated with prior thromboembolism, sleep apnea, higher BMI, and impaired functional status. Overall, adverse outcomes are uncommon in most bariatric surgery patients. (abstract)
Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.